fullerene c60 has been researched along with uk 68798 in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (uk 68798) | Trials (uk 68798) | Recent Studies (post-2010) (uk 68798) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 698 | 65 | 199 |
| Protein | Taxonomy | fullerene c60 (IC50) | uk 68798 (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1455 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuervo, JE; Durdagi, S; Noskov, SY; Zhao, C | 1 |
1 review(s) available for fullerene c60 and uk 68798
| Article | Year |
|---|---|
Atomistic models for free energy evaluation of drug binding to membrane proteins.
Topics: Channelopathies; Drug Design; Entropy; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fullerenes; HIV Protease; Ion Channels; Ligands; Membrane Proteins; Models, Molecular; Molecular Dynamics Simulation; Phenethylamines; Protein Binding; Sulfonamides | 2011 |